{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:32:13Z","timestamp":1777303933142,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873171"],"award-info":[{"award-number":["81873171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jep.2026.121667","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:38:18Z","timestamp":1775666298000},"page":"121667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Guben Qingyuan Herbal Medicine delays enzalutamide resistance in prostate cancer by alleviating tumor hypoxia and reprogramming energy metabolism in cancer stem cells"],"prefix":"10.1016","volume":"366","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3999-3818","authenticated-orcid":false,"given":"Xudong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xixi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suping","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiazheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2026.121667_bib1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/10717544.2022.2048133","article-title":"Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles","volume":"29","author":"Al-Rabia","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jep.2026.121667_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113047","article-title":"Ganoderma lucidum: a rational pharmacological approach to surmount cancer","volume":"260","author":"Ahmad","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2026.121667_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.copbio.2007.10.007","article-title":"Cancer stem cells in solid tumors","volume":"18","author":"Ailles","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jep.2026.121667_bib4","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1200\/JCO.19.00799","article-title":"ARCHES: a randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men metastatic hormone-sensitive prostate cancer","volume":"37","author":"Armstrong","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jep.2026.121667_bib5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/jcp.29044","article-title":"Cancer stem cells: a review from origin to therapeutic implications","volume":"235","author":"Atashzar","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jep.2026.121667_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00280-023-04583-y","article-title":"Pharmacokinetics and pharmacodynamics of Rh2 and aPPD ginsenosides in prostate cancer: a drug interaction perspective","volume":"92","author":"Ben-Eltriki","year":"2023","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"10","key":"10.1016\/j.jep.2026.121667_bib7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/13543784.2025.2573647","article-title":"Androgen receptor pathway signaling inhibitors in development for prostate cancer therapy","volume":"34","author":"Bleve","year":"2025","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.jep.2026.121667_bib8","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ctrv.2015.08.002","article-title":"Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer","volume":"41","author":"Buttigliero","year":"2015","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.jep.2026.121667_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/bjc.2016.29","article-title":"Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition","volume":"114","author":"Byrne","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jep.2026.121667_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijrobp.2005.11.044","article-title":"An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance","volume":"65","author":"Carnell","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jep.2026.121667_bib11","article-title":"CAF-mediated regulation of prostate cancer stem cell stemness via the Wnt\/\u03b2-catenin and SDF-1\/CXCR4 pathways in castration-resistant prostate cancer","volume":"13","author":"Chen","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jep.2026.121667_bib12","first-page":"1480","article-title":"Study on guben Qingyuan prescription combined with androgen deprivation therapy to control castration-resistant prostate cancer based on Wnt pathway of cancer stem cells","volume":"39","author":"Chen","year":"2023","journal-title":"Chinese Archives of Traditional chinese medicine"},{"key":"10.1016\/j.jep.2026.121667_bib13","first-page":"1","article-title":"Study on effect of gubenqingyuan prescription on prostate cancer resistance to enzalutamide by regulating the CAF-cancer stem cell axis","author":"Chen","year":"2025","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"key":"10.1016\/j.jep.2026.121667_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.07.021","article-title":"Deacetylation of \u03b2-catenin by SIRT1 regulates self-renewal and oncogenesis of liver cancer stem cells","volume":"463","author":"Chen","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jep.2026.121667_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa1903835","article-title":"Enzalutamide with standard first-line therapy in metastatic prostate cancer","volume":"381","author":"D","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jep.2026.121667_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.710","article-title":"Intricate relationship between cancer stemness, metastasis, and drug resistance","volume":"5","author":"Dakal","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.jep.2026.121667_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40643-024-00805-0","article-title":"Harnessing the potency of scorpion venom-derived proteins: applications in cancer therapy","volume":"11","author":"El-Qassas","year":"2024","journal-title":"Bioresour Bioprocess"},{"key":"10.1016\/j.jep.2026.121667_bib18","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1186\/s12885-025-15152-2","article-title":"Curcumin in prostate cancer: a systematic review of molecular mechanisms and nanoformulated therapeutic strategies","volume":"25","author":"Esmaeli","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jep.2026.121667_bib19","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/onc.2014.115","article-title":"Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects","volume":"34","author":"Ferraldeschi","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.jep.2026.121667_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clgc.2015.03.006","article-title":"Hypoxia and prostate cancer aggressiveness: a tale with many endings","volume":"13","author":"Fraga","year":"2015","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.jep.2026.121667_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101227","article-title":"TGF\u03b2-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt\/\u03b2-catenin signaling pathway","volume":"81","author":"Ge","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.jep.2026.121667_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1091\/mbc.e08-08-0792","article-title":"PCAF acetylates \u03b2-Catenin and improves its stability","volume":"20","author":"Ge","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jep.2026.121667_bib23","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1038\/s41467-018-07411-7","article-title":"Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen\/AR-targeted therapy","volume":"9","author":"Geng","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jep.2026.121667_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10565-025-10046-2","article-title":"ADT increases prostate cancer cell invasion via altering AR\/SALL4\/SOX2-OCT4 stem cell signaling","volume":"41","author":"Guo","year":"2025","journal-title":"Cell Biol. Toxicol."},{"issue":"8","key":"10.1016\/j.jep.2026.121667_bib25","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1097\/JS9.0000000000001479","article-title":"Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: a global-scale, cross-sectional, and large-sample informatics study","volume":"110","author":"Guo","year":"2024","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.jep.2026.121667_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/pros.23469","article-title":"Matrine inhibits the progression of prostate cancer by promoting expression of GADD45B","volume":"78","author":"Huang","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.jep.2026.121667_bib27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3892\/ijo.2016.3805","article-title":"Matrine suppresses invasion of castration-resistant prostate cancer cells by downregulating MMP-2\/9 via NF-\u03baB signaling pathway","volume":"50","author":"Huang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jep.2026.121667_bib28","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jep.2026.121667_bib29","first-page":"289","article-title":"Summary of Professor Lin Hongsheng's medication ideas for treating tumors","volume":"5","author":"Jiang","year":"2012","journal-title":"Global Traditional Chinese Medicine"},{"key":"10.1016\/j.jep.2026.121667_bib30","doi-asserted-by":"crossref","first-page":"9271","DOI":"10.1158\/0008-5472.CAN-09-1605","article-title":"Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity","volume":"69","author":"Kim","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jep.2026.121667_bib31","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1349-7006.2009.01195.x","article-title":"Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia","volume":"100","author":"Kizaka-Kondoh","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jep.2026.121667_bib32","first-page":"485","article-title":"Chinese herbal medicines for prostate cancer therapy: from experimental research to clinical practice","volume":"15","author":"Kong","year":"2023","journal-title":"Chin. Herb. Med."},{"key":"10.1016\/j.jep.2026.121667_bib33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ceb.2012.01.005","article-title":"From stem cells to cancer stem cells: HIF takes the stage","volume":"24","author":"Lee","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jep.2026.121667_bib34","doi-asserted-by":"crossref","first-page":"30678","DOI":"10.1074\/jbc.C600120200","article-title":"Differentiation arrest by hypoxia","volume":"281","author":"Lin","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jep.2026.121667_bib35","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4161\/cbt.9.12.12347","article-title":"Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics","volume":"9","author":"Lin","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jep.2026.121667_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3892\/or.2025.8917","article-title":"Effect of Polygonatum Sibiricum polysaccharides on nude mice model of prostate cancer PC-3 cells","volume":"54","author":"Liu","year":"2025","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jep.2026.121667_bib37","first-page":"102","article-title":"Academic thoughts of Professor Lin Hongsheng in applying consolidate constitution to eliminate pathogenic factors to treat tumor","volume":"11","author":"Liu","year":"2016","journal-title":"World Chinese Med."},{"key":"10.1016\/j.jep.2026.121667_bib38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jep.2026.121667_bib39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.stem.2014.02.012","article-title":"Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency","volume":"14","author":"Mathieu","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jep.2026.121667_bib40","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130676","article-title":"Defining normoxia, physoxia and hypoxia in tumours\u2014implications for treatment response","volume":"87","author":"McKeown","year":"2014","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.jep.2026.121667_bib41","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/ijc.27796","article-title":"Androgen deprivation results in time-dependent hypoxia in LNCaP prostate tumours: informed scheduling of the bioreductive drug AQ4N improves treatment response","volume":"132","author":"Ming","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jep.2026.121667_bib42","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/ijc.27796","article-title":"Androgen deprivation results in time-dependent hypoxia in LNCaP prostate tumours: informed scheduling of the bioreductive drug AQ4N improves treatment response","volume":"132","author":"Ming","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jep.2026.121667_bib43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.stem.2010.07.007","article-title":"Oxygen in stem cell biology: a critical component of the stem cell niche","volume":"7","author":"Mohyeldin","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jep.2026.121667_bib44","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0090-4295(02)01858-7","article-title":"Hypoxic prostate\/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings","volume":"60","author":"Movsas","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.jep.2026.121667_bib45","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00000421-200110000-00009","article-title":"Hypoxia in human prostate carcinoma: an Eppendorf PO2 study","volume":"24","author":"Movsas","year":"2001","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.jep.2026.121667_bib46","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrurol.2017.144","article-title":"WNT signalling in prostate cancer","volume":"14","author":"Murillo-Garz\u00f3n","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jep.2026.121667_bib47","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0360-3016(03)01621-3","article-title":"Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer","volume":"58","author":"Parker","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jep.2026.121667_bib48","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0360-3016(03)01621-3","article-title":"Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer","volume":"58","author":"Parker","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jep.2026.121667_bib49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrurol.2014.227","article-title":"Enzalutamide AFFIRMs its benefits","volume":"11","author":"Phillips","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jep.2026.121667_bib50","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1128\/MCB.18.5.2845","article-title":"Regulation of proliferation-survival decisions during tumor cell hypoxia","volume":"18","author":"Schmaltz","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jep.2026.121667_bib51","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.gt.3301124","article-title":"Development of a hypoxia-responsive vector for tumor-specific gene therapy","volume":"7","author":"Shibata","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.jep.2026.121667_bib52","first-page":"751","article-title":"Progress in the clinical application of centipede in andrilogy","volume":"29","author":"Shi","year":"2023","journal-title":"Zhonghua Nan ke Xue"},{"issue":"2","key":"10.1016\/j.jep.2026.121667_bib53","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41391-024-00803-5","article-title":"A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer","volume":"28","author":"Shore","year":"2025","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.jep.2026.121667_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrm2354","article-title":"The role of oxygen availability in embryonic development and stem cell function","volume":"9","author":"Simon","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jep.2026.121667_bib55","article-title":"Cancer stem cell in prostate cancer progression, metastasis and therapy resistance","volume":"1878","author":"Verma","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.jep.2026.121667_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2005.06.004","article-title":"Roles and regulation of Wnt signaling and \u03b2-catenin in prostate cancer","volume":"237","author":"Verras","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jep.2026.121667_bib57","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.neo.7900192","article-title":"Green fluorescent protein is a suitable reporter of tumor hypoxia despite an oxygen requirement for chromophore formation","volume":"3","author":"Vordermark","year":"2001","journal-title":"Neoplasia"},{"key":"10.1016\/j.jep.2026.121667_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117829","article-title":"PSMA targeted therapy: from molecular mechanisms to clinical breakthroughs in castration-resistant prostate cancer","volume":"296","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jep.2026.121667_bib59","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1038\/s41467-020-15396-5","article-title":"The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jep.2026.121667_bib60","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2016.05.018","article-title":"ASC-J9\u00ae suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L","volume":"379","author":"Wang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jep.2026.121667_bib61","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.eururo.2017.04.005","article-title":"Preclinical study using Malat1 small interfering RNA or androgen receptor splicing variant 7 degradation enhancer ASC-J9\u00ae to suppress enzalutamide-resistant prostate cancer progression","volume":"72","author":"Wang","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jep.2026.121667_bib62","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pharmthera.2016.04.009","article-title":"Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer","volume":"164","author":"Wigerup","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jep.2026.121667_bib63","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1007\/s12094-023-03093-w","article-title":"Hypoxia promotes conversion to a stem cell phenotype in prostate cancer cells by activating HIF-1\u03b1\/Notch1 signaling pathway","volume":"25","author":"Wu","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.jep.2026.121667_bib64","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41419-020-2714-7","article-title":"Oxidized ATM promotes breast cancer stem cell enrichment through energy metabolism reprogram-mediated acetyl-CoA accumulation","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jep.2026.121667_bib65","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tcb.2025.04.002","article-title":"New job for an old tool: PI3K\u03b2 phosphorylates OGT to regulate acetyl-CoA in glioblastoma","volume":"35","author":"Young","year":"2025","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jep.2026.121667_bib66","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.biocel.2012.08.022","article-title":"Cancer stem cells","volume":"44","author":"Yu","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jep.2026.121667_bib67","article-title":"Research status and molecular mechanism of the traditional Chinese medicine and antitumor therapy combined strategy based on tumor microenvironment","volume":"11\u20132020","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jep.2026.121667_bib68","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1038\/s41388-018-0161-z","article-title":"CREPT facilitates colorectal cancer growth through inducing Wnt\/\u03b2-catenin pathway by enhancing p300-mediated \u03b2-catenin acetylation","volume":"37","author":"Zhang","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jep.2026.121667_bib70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11523-025-01188-8","article-title":"Can PARP inhibitors benefit patients with homologous recombination repair-proficient castration-resistant prostate cancer? A meta-analysis","volume":"21","author":"Zhou","year":"2026","journal-title":"Target Oncol"}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126005180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126005180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:32:28Z","timestamp":1777300348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874126005180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":69,"alternative-id":["S0378874126005180"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2026.121667","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guben Qingyuan Herbal Medicine delays enzalutamide resistance in prostate cancer by alleviating tumor hypoxia and reprogramming energy metabolism in cancer stem cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2026.121667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121667"}}